Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Harvard Business School
McKinsey
Baxter
Mallinckrodt

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Becton Dickinson Co Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for BECTON DICKINSON CO, and what generic alternatives to BECTON DICKINSON CO drugs are available?

BECTON DICKINSON CO has two approved drugs.

There are six US patents protecting BECTON DICKINSON CO drugs.

There are thirty-one patent family members on BECTON DICKINSON CO drugs in thirteen countries.

Summary for Becton Dickinson Co
International Patents:31
US Patents:6
Tradenames:6
Ingredients:1
NDAs:2

Drugs and US Patents for Becton Dickinson Co

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Becton Dickinson Co CHLORAPREP ONE-STEP FREPP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-003 Apr 26, 2002 OTC Yes Yes   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-004 Aug 20, 2003 OTC Yes Yes 6,536,975   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes 7,182,536   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-006 Nov 21, 2006 OTC Yes Yes 7,182,536   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006 OTC Yes Yes 6,729,786   Start Trial Y   Start Trial
Becton Dickinson Co CHLORAPREP TRIPLE SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021555-003 Jun 10, 2009 OTC Yes Yes   Start Trial   Start Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006 OTC Yes Yes 7,241,065   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Expired US Patents for Becton Dickinson Co

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 5,690,958   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-004 Aug 20, 2003 5,690,958   Start Trial
Becton Dickinson Co CHLORAPREP SINGLE SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021555-002 May 10, 2005 5,690,958   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP FREPP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-003 Apr 26, 2002 D396911   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP SEPP chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021555-001 Oct 7, 2002 5,690,958   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP FREPP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-003 Apr 26, 2002 5,752,363   Start Trial
Becton Dickinson Co CHLORAPREP ONE-STEP chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-001 Jul 14, 2000 5,538,353   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Start Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Moodys
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews